Richard J Mckittrick, MD | |
12200 W 110th St, Overland Park, KS 66210-4045 | |
(913) 574-2650 | |
(913) 574-2769 |
Full Name | Richard J Mckittrick |
---|---|
Gender | Male |
Speciality | Medical Oncology |
Experience | 38 Years |
Location | 12200 W 110th St, Overland Park, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932170537 | NPI | - | NPPES |
100126220C | Medicaid | KS | |
1932170537 | Medicaid | MO | |
100126220D | Medicaid | KS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 108885 (Missouri) | Secondary |
207RH0003X | Internal Medicine - Hematology & Oncology | 0423158 (Kansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Kansas Hospital | Kansas city, KS | Hospital |
St Joseph Medical Center | Kansas city, MO | Hospital |
Lawrence Memorial Hospital | Lawrence, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Kansas Hospital Authority | 9436054798 | 250 |
University Of Kansas Hospital Authority | 9436054798 | 250 |
News Archive
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia.
A new technique that has the potential to treat inherited diseases by removing genetic defects has been shown for the first time to hinder retinal degeneration in rats with a type of inherited blindness, according to a Cedars-Sinai study.
A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes.
Novavax, Inc. announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age or older (older adults). This randomized, double-blind, active-controlled study is comparing the safety, tolerability and immunogenicity of two different doses (15 mcg and 60 mcg) of Novavax's trivalent seasonal influenza VLP vaccine to a commercially available trivalent inactivated vaccine, TIV (FluzoneĀ®).
OrSense Ltd., announced today that two oral presentations on the clinical value of its NBM 200 non-invasive hemoglobin (Hb) monitor for maternal health and anemia monitoring prior, during and post delivery of pregnant women will be presented at the 4th Asia Pacific Congress on Controversies in Obstetrics Gynecology and Infertility (COGI).
› Verified 9 days ago
Entity Name | University Of Kansas Hospital Authority |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528019502 PECOS PAC ID: 9436054798 Enrollment ID: O20110607000604 |
News Archive
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia.
A new technique that has the potential to treat inherited diseases by removing genetic defects has been shown for the first time to hinder retinal degeneration in rats with a type of inherited blindness, according to a Cedars-Sinai study.
A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes.
Novavax, Inc. announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age or older (older adults). This randomized, double-blind, active-controlled study is comparing the safety, tolerability and immunogenicity of two different doses (15 mcg and 60 mcg) of Novavax's trivalent seasonal influenza VLP vaccine to a commercially available trivalent inactivated vaccine, TIV (FluzoneĀ®).
OrSense Ltd., announced today that two oral presentations on the clinical value of its NBM 200 non-invasive hemoglobin (Hb) monitor for maternal health and anemia monitoring prior, during and post delivery of pregnant women will be presented at the 4th Asia Pacific Congress on Controversies in Obstetrics Gynecology and Infertility (COGI).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Richard J Mckittrick, MD 11300 Corporate Ave, Lenexa, KS 66219-1374 Ph: (913) 574-2650 | Richard J Mckittrick, MD 12200 W 110th St, Overland Park, KS 66210-4045 Ph: (913) 574-2650 |
News Archive
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia.
A new technique that has the potential to treat inherited diseases by removing genetic defects has been shown for the first time to hinder retinal degeneration in rats with a type of inherited blindness, according to a Cedars-Sinai study.
A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes.
Novavax, Inc. announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age or older (older adults). This randomized, double-blind, active-controlled study is comparing the safety, tolerability and immunogenicity of two different doses (15 mcg and 60 mcg) of Novavax's trivalent seasonal influenza VLP vaccine to a commercially available trivalent inactivated vaccine, TIV (FluzoneĀ®).
OrSense Ltd., announced today that two oral presentations on the clinical value of its NBM 200 non-invasive hemoglobin (Hb) monitor for maternal health and anemia monitoring prior, during and post delivery of pregnant women will be presented at the 4th Asia Pacific Congress on Controversies in Obstetrics Gynecology and Infertility (COGI).
› Verified 9 days ago
Dr. Matthew P Harrison, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 10116 W 105th St, Overland Park, KS 66212 Phone: 913-541-0510 Fax: 913-541-1852 | |
Louay K. Sabih, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 10550 Marty St Ste 201, Overland Park, KS 66212 Phone: 913-341-4000 Fax: 913-383-2868 | |
Kimberly Foley Nagel, ARNP Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5701 W 119th St, Suite 345, Overland Park, KS 66209 Phone: 913-339-9046 Fax: 913-339-9018 | |
Dr. Paul G Diederich, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 10787 Nall Ave, Ste. 310, Overland Park, KS 66211 Phone: 913-945-6900 Fax: 913-945-6970 | |
Mini R Abraham, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 10000 College Blvd, Overland Park, KS 66210 Phone: 913-258-5055 Fax: 913-258-5057 | |
Jeena Viji Eapen, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 10540 Marty St Ste 100, Overland Park, KS 66212 Phone: 913-660-1616 Fax: 913-660-0998 | |
Dr. Arnold Leslie Katz, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 10550 Quivira Road, Suite 320, Overland Park, KS 66215 Phone: 913-888-3231 Fax: 913-888-7281 |